Literature DB >> 15721004

What causes acute coronary syndromes? Applying Koch's postulates.

Claudia Monaco1, Anthony Mathur, John F Martin.   

Abstract

The term "acute coronary syndromes" (ACS) is used to describe a heterogeneous spectrum of clinical conditions. This includes myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina. These conditions are linked by a similar constellation of signs and symptoms but not necessarily by a common pathophysiology. They are syndromes. Several different hypotheses exist that have attempted to explain the pathological mechanisms that are involved in these conditions, however, it is not clear whether ACS are caused by variations of a single disease process or by several disease processes. The contribution of both vessel wall- and blood-related factors in the pathogenesis of acute coronary syndromes is herein discussed with the guidance of Koch's postulates.

Entities:  

Mesh:

Year:  2005        PMID: 15721004     DOI: 10.1016/j.atherosclerosis.2004.10.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  The effects of tea on psychophysiological stress responsivity and post-stress recovery: a randomised double-blind trial.

Authors:  Andrew Steptoe; E Leigh Gibson; Raisa Vuononvirta; Emily D Williams; Mark Hamer; Jane A Rycroft; Jorge D Erusalimsky; Jane Wardle
Journal:  Psychopharmacology (Berl)       Date:  2006-09-30       Impact factor: 4.530

2.  Pathophysiological processes underlying emotional triggering of acute cardiac events.

Authors:  Philip C Strike; Kesson Magid; Daisy L Whitehead; Lena Brydon; Mimi R Bhattacharyya; Andrew Steptoe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-02       Impact factor: 11.205

Review 3.  The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes.

Authors:  John F Martin; Steen D Kristensen; Anthony Mathur; Erik L Grove; Fizzah A Choudry
Journal:  Nat Rev Cardiol       Date:  2012-11       Impact factor: 32.419

4.  Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.

Authors:  L Pasalic; E Wing-Lun; J K Lau; H Campbell; G J Pennings; E Lau; D Connor; H P Liang; D Muller; L Kritharides; P J Hogg; V M Chen
Journal:  J Thromb Haemost       Date:  2018-05-08       Impact factor: 5.824

5.  Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity.

Authors:  Abhishek Joshi; Lukas E Schmidt; Sean A Burnap; Ruifang Lu; Melissa V Chan; Paul C Armstrong; Ferheen Baig; Clemens Gutmann; Peter Willeit; Peter Santer; Temo Barwari; Konstantinos Theofilatos; Stefan Kiechl; Johann Willeit; Timothy D Warner; Anthony Mathur; Manuel Mayr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-11-23       Impact factor: 8.311

Review 6.  Big data from electronic health records for early and late translational cardiovascular research: challenges and potential.

Authors:  Harry Hemingway; Folkert W Asselbergs; John Danesh; Richard Dobson; Nikolaos Maniadakis; Aldo Maggioni; Ghislaine J M van Thiel; Maureen Cronin; Gunnar Brobert; Panos Vardas; Stefan D Anker; Diederick E Grobbee; Spiros Denaxas
Journal:  Eur Heart J       Date:  2018-04-21       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.